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Abstract
Background: G-protein coupled receptors (GPCR), also referred as Free Fatty Acid Receptors (FFAR), are widely
studied within human medicine as drug targets for metabolic disorders. To combat metabolic disorders prevalent
in dairy cows during the transition period, which co-occur with negative energy balance and changes to lipid and
glucose metabolism, it may be helpful to identify locations and roles of FFAR and other members of the GPCR
family in bovine tissues.
Results: Quantitative RT-PCR (qPCR) of subcutaneous adipose, liver, and PMNL samples during the transition period
(-10, +7, and +20 or +30 d) were used for expression profiling of medium- (MCFA) and long-chain fatty acid (LCFA)
receptors GPR120 and GPR40, MCFA receptor GPR84, and niacin receptor HCAR2/3. Adipose samples were obtained
from cows with either high (HI; BCS ≥ 3.75) or low (LO; BCS ≤ 3.25) body condition score (BCS) to examine whether
FFAR expression is correlated with this indicator of health and body reserves. Supplementation of rumen-protected
methionine (MET), which may improve immune function and production postpartum, was also compared with
unsupplemented control (CON) cows for liver and blood polymorphonuclear leukocytes (PMNL) samples. In adipose
tissue, GPR84 and GPR120 were differentially expressed over time, while GPR40 was not expressed; in PMNL, GPR40
was differentially expressed over time and between MET vs. CON, GPR84 expression differed only between dietary
groups, and GPR120 was not expressed; in liver, GPCR were either not expressed or barely detectable.
Conclusions: The data indicate that there is likely not a direct role in liver for the selected GPCR during the
transition period, but they do play variable roles in adipose and PMN. In future, these receptors may prove useful
targets and/or markers for peripartal metabolism and immunity.
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Background
The G-protein coupled receptor (GPCR) superfamily is
one of the largest families of receptor proteins, compris-
ing 1% or more of the human genome, and as much as
5% in simpler organisms like the nematode [1, 2]. GPCR
are also termed as seven transmembrane receptors, from
their identifying structure of seven α-helices spanning
the membrane. They can receive a variety of ligand clas-
ses from the extracellular environment, and stimulate
intracellular signaling cascades that may begin with ac-
tion of associated G-proteins [3]. Although GPCR in
general are extensively-researched drug targets due to
their abundance and activities, those which have meta-
bolic roles may be targets for treating or preventing
metabolic and inflammatory diseases in dairy cows, as
well. This could especially be of value in the transition
period, where prevalence rates and outcomes of diseases
are often at their worst [4].
GPCR with fatty acids (FA), and especially longer-chain
FA, ligands are among some of the most interesting tar-
gets, due to the ability of saturated versus unsaturated fats
to evoke different signals within cells [5, 6], and for signal-
ing potency to vary based on chain length and degree of
saturation [7–9]. There is also potential to link nutrition,
FA metabolism, and immunity among such signaling
pathways [10]. For instance, GPR40 and GPR120 may be
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implicated in anti-inflammation in macrophages, but are
currently of greater interest for their metabolic effects.
These receptors have been connected with obesity, insulin
responses, and inflammation subsequent to these condi-
tions [10]. GPR40 may have a unique contribution to im-
mune function, as it has been shown to stimulate calcium
mobilization in bovine neutrophils, a necessary signal for
neutrophil activation and function [11]. GPR84 has been
identified in cells of both the innate and adaptive immune
system, including PMNL, and plays a role in pro-
inflammatory responses, e.g., cytokine production [10].
GPR109A also links metabolism and immunity; it has
been detected in adipose and macrophages and primar-
ily exerts anti-lipolytic effects [12]. For a summary of
these genes and their functions, see Table 1 [10, 11].
The present study also involved an examination of
GPCR in adipose tissue, and more specifically cows with
different degrees of adiposity as evaluated through the
body condition score (BCS) at 21 d prior to parturition.
BCS represents energy storage status [13], which is vitally
important to the peripartal dairy cow, as early lactation
proceeds at the expense of stored energy [14]. What is
considered as an optimal score can vary, and may instead
be expressed as a range, but is currently thought to be
around 3.25 near calving [15]. Generally, however, rela-
tively higher prepartum or calving BCS is correlated with
greater BCS [16] and/or body weight [17] loss postcalving.
Thus, although all cows experience negative energy bal-
ance (NEB) after calving [4], higher BCS cows are at
higher risk for deeper NEB and excess lipid mobilization
– adverse conditions for an optimal transition. Lower BCS
may be considered relatively more optimal for health, al-
though very thin cows have been found to produce less
milk [18]. Thus, comparison of FA-sensing receptor
expression in both an optimal/thin and a suboptimal/fat
group of cows (here, divided as LO = BCS ≤ 3.25, and
HI = BCS ≥ 3.75, respectively) could be of value.
The effect of supplementing rumen-protected methio-
nine (MET) was also considered for liver and blood poly-
morphonuclear leukocytes (PMNL) analyses of GPCR.
Previous work by our group demonstrated that MET can
improve liver function, immune and antioxidant status,
milk yield and protein levels, and may also have benefi-
cial effects on dry matter intake (DMI) around calving
[19–21]. Since the GPCR studied here are closely linked
to lipid and glucose metabolism and inflammation, it
seemed worthwhile to investigate whether gene expres-
sion in liver or PMNL is changed with supplementa-
tion, and how that relates to observed cow-level effects.
Because the FFAR are not yet well-studied in ruminants
[22], the aim of the present study was to assess patterns
and levels of receptor expression in periparturient dairy
cows. Furthermore, because BCS and supplemental MET
can affect production, immune status, and metabolism, we




Cows in the present study were a subset from the experi-
ment of Zhou et al. [21]. Cows were blocked according to
lactation and calving measures, and fed the same close-up
(1.52 Mcal/kg DM; -21 d until calving) and lactation (1.71
Mcal/kg DM; calving until +30 d) diets as a total mixed
ration (TMR) once daily (0630 h). Cows were housed in
an enclosed, ventilated barn during the dry period and fed
using an individual gate system (American Calan Inc.,
Northwood, NH), and moved to a tie-stall barn with
Table 1 Genes of interest and their functions
Gene Name Gene Function References
GPR40 M/LCFA receptor expressed in pancreatic α- and β-cells, enteroendocrine cells, immune cells, taste buds, and
the central nervous system. Stimulation invokes intracellular calcium response and ERK signaling, or increases
in cAMP. Mediates insulin release from β-cells, glucagon release from α-cells, and incretins in the gastrointestinal
tract in response to free fatty acid (FFA) ligands, playing a central role in glucose homeostasis. Promotes activation
and superoxide production in bovine neutrophils. May regulate secretion of brain-derived neurotrophic factor in
neuroblastoma cells.
[8, 11, 38, 48, 66]
GPR120 M/LCFA receptor expressed in adipocytes and adipose tissue, macrophages, enteroendocrine cells, pancreatic
α-cells, taste buds, and lungs. Stimulation invokes intracellular calcium response and ERK signaling. Stimulation
with ω-3 FA leads to β-arrestin2-mediated inhibition of TAK1 (i.e.: anti-inflammatory signaling). Promotes glucose
uptake via GLUT4 and G-protein-related insulin stimulatory effects in adipocytes. Promotes incretin (e.g., GLP-1)
release in gastrointestinal tract, and glucagon release in α-cells. Reduces inflammatory gene expression in
macrophages and adipose, as well as macrophage invasion into adipose tissue.
[38, 44, 49, 67, 68]
GPR84 MCFA receptor expressed in adipocytes and immune cells, including leukocytes. Expression is upregulated
in macrophages by LPS. Promotes pro-inflammatory cytokine and chemokine signals.
[38, 69, 70]
HCAR2/3 Nicotinic acid and butyrate/β-hydroxybutyrate receptor expressed in adipose tissue, immune cells, spleen, colon,
pancreatic β-cells, and mammary epithelium. Expression is upregulated in adipose and macrophages by LPS and
other pro-inflammatory factors. Activation by niacin or BHBA decreases cAMP levels in adipose tissue, thereby
reducing lipolysis, plasma FFA, and availability for triglyceride synthesis. Decreases in cAMP also occur in β-cells,
inhibiting insulin release. Promotes release of prostaglandins from immune cells, including macrophages. Invokes
apoptotic pathways in neutrophils and some cancer cells (e.g., breast and colon cancer).
[12, 46, 71–73]
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individual feed bunks after calving. Throughout these pe-
riods, diets were top-dressed with either no supplement
(CON), or Smartamine M (Adisseo NA) rumen-protected
methionine (MET). Complete details of supplementation
may be found elsewhere [21]. Lactating cows were milked
three times daily (0600, 1400, and 2200 h).
Ten and eleven cows from each group (CON and
MET) were used in the present study to compare PMNL
and liver gene expression, respectively. Additionally, twenty
cows that had received adipose biopsies were retroactively
grouped by their BCS (see below) at -3 wk from calving
(i.e.: upon entry into the close-up dry period), such that 10
cows with BCS ≥ 3.75 (HI; avg. = 3.83 ± 0.12) were com-
pared to 10 cows with BCS ≤ 3.25 (LO; avg. = 3.11 ± 0.16)
for adipose gene expression. The effect of supplementation
was not considered in this tissue.
Sample collection
The BCS were assigned weekly during the experiment,
along with body weight measurements. BCS was deter-
mined on a scale of 1–5 with quarter-point increments,
where 1 = thin and 5 = obese. Two scores were given inde-
pendently each week, so that the average was taken and
used for statistical analyses and retroactive grouping. Indi-
vidual and average BCS loss of cows in each group were
also calculated between Prepartum (-21 d) and Postpar-
tum (+21 d) time points. At -10, +7, and +20 d from calv-
ing, energy balance (Table 2) was calculated as described
previously [23] in the subset of cows which received adi-
pose biopsies.
Blood was only collected from those cows receiving liver
biopsies or scheduled for PMNL retrieval. Serum and
plasma were collected for analyses into vacutainers (BD
Vacutainer; BD and Co., Franklin Lakes, NJ) containing
clot activator or lithium heparin, respectively, at -10, +8,
and +30 d relative to parturition. Blood for serum samples
was kept at 21 °C, and blood for plasma kept on ice, until
centrifugation. Methods for analyses of IL-1β, reactive
oxygen metabolites (ROM), and myeloperoxidase (MPO)
as indicators of systemic inflammation and oxidative stress
was reported previously [20].
Full protocols for relevant tissue biopsies have been pre-
viously described [24, 25]. Briefly, cows were given local
anesthesia prior to biopsy. The same cows were not used
for liver biopsies as for adipose biopsies. Liver was sam-
pled via puncture biopsy at -10, +7, and +30 d from
parturition via puncture biopsy, while adipose biopsies
from alternate sides of the tail-head region were taken
at -10, +7, and +20 d using a blunt dissection method.
Both liver and adipose samples were snap-frozen in liquid
nitrogen and transferred to a freezer at -80 °C until RNA
extraction and further analyses.
PMN Isolation
Blood samples for collection of PMNL were drawn into
vacutainers containing acid citrate dextrose (ACD Solution
A; Fisher Scientific) from the coccygeal vein at -10, +7,
and +30 d relative to parturition. Samples were placed
on ice until PMNL isolation by sample centrifugation,
cell lysing, and several rounds of centrifugation with
PBS washing. Both purity and viability of PMNL were
greater than 90%. Complete details of this process can
be found in Zhou et al. [26]. Briefly, a 50 μL aliquot of
PMNL was incubated for 15 min on ice with 100 μL of
primary anti-bovine granulocyte monoclonal antibody
(Cat. No. BOV2067, Washington State University, Pullman,
USA) solution (15 μg/mL in 1 × PBS). The aliquot was then
washed twice with 2 mL 1 × PBS and incubated for another
15 min on ice, protected from light, with 50 μL of second-
ary phycoerythrin-labeled secondary antibody (Cat. No.
1020–09S, Southern Biotech, Birmingham, AL) (4 μg/mL
in 1 × PBS), and 50 μL of Propidium iodide (50 μg/mL)
prior to flow cytometry. Isolated PMNL were homoge-
nized at full speed in a solution of 2 mL TRIzol re-
agent (Invitrogen, Carlsbad, CA) with 1 μL linear
acrylamide (Ambion, Inc., Austin, TX). Homogenate
was stored at -80 °C in RNA-free microcentrifuge
tubes (Fisher Scientific, Pittsburgh, PA).
RNA Isolation
To proceed with RNA extraction, 40 mg liver and 200 mg
adipose were thawed and homogenized in QIAzol reagent
(Qiagen, Hilden, Germany). Extraction of RNA was per-
formed with the miRNeasy kit (Qiagen) following the man-
ufacturer’s protocols. Samples were treated on-column
with DNaseI (Qiagen). Prior to storage, RNA purity was
confirmed using a NanoDrop ND-1000 (NanoDrop
Technologies, Rockland, DE) OD260nm/OD280nm ratio,
and RNA quality was recorded using a 2100 Bioanalyzer
(Agilent Technologies, Inc., Santa Clara, CA) RNA in-
tegrity number (RIN). All liver samples had RIN scores
Table 2 Least squares means of energy balance (EB) and
energy balance as a percentage of requirements (EB % Req) in
transition cows with high (HI; BCS ≥ 3.75) or low (LO; BCS≤ 3.25)
body condition score prepartum and postpartum. This data only
represents the subset of cows used for adipose gene expression
BCS1 SEM2 P-value
HI LO BCS Time BCS × Time
Prepartum
EB 1.89 2.16 1.08 0.86 - -
EB % Req 112.35 115.62 7.13 0.75 - -
Postpartum
EB −11.87a −5.52b 2.00 0.03 0.03 0.14
EB % Req 70.85a 86.20b 4.74 0.03 <0.01 0.30
a,bStatistical difference (P < 0.05) among time points within the same group
1Body condition score
2Largest standard error of the mean
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above 8.0. Average RIN scores for the other two tis-
sues were as follows: 6.44 ± 0.21 for adipose and 6.68
± 0.02 for PMNL.
Real-time Quantitative PCR
Previous publications by our group [27] outlined the full
protocols. Briefly, 100 ng of RNA, plus reagents including:
1 μg of dT18 (Operon Biotechnologies, Huntsville, AL),
1 μL of 10 mmol/L dNTP mix (Invitrogen Corp., Carlsbad,
CA), 1 μL of random primers (3 mg/μL; Invitrogen Corp.),
and 10 μL of DNase-/RNase-free water, were incubated at
65 °C for 5 min, then placed on ice for 3 min. Six μL of
master mix, including: 5.5 μL of 5× reaction buffer, 0.25 μL
(50 U) of RevertAid reverse transcriptase (Fermentas Inc.,
Glen Burnie, MD), and 0.25 μL of RNase inhibitor (10 U,
Promega, Madison, WI), was then added to complete
cDNA synthesis.
Primer design protocols have also been published
previously [28]. Except for bovine GPR40 [29], primer
sequences were obtained using Primer Express 3.0. Pri-
mer information and obtained products are listed in
Additional file 1: Table S1 and S2, respectively. Quanti-
tative PCR was performed using 4 μL of diluted cDNA
plus a mixture of 5 μL of 1× SYBR Green master mix
(Applied Biosystems, CA), 0.4 μL each of the 10 μmol/L
forward and reverse primers, and 0.2 μL of DNase-/
RNase-free water in a MicroAmp Optical 384-Well Re-
action Plate (Applied Biosystems, Foster City, CA).
Each sample was run in duplicate, while a negative con-
trol and serially diluted, pooled cDNA were run in trip-
licate to create a 6-point relative standard curve (User
Bulletin #2, Applied Biosystems). PCR reactions were
performed in an ABI Prism 7900 HT SDS instrument
(Applied Biosystems) under the following conditions: 2
min at 50 °C, 10 min at 95 °C, 40 cycles of 15 s at 95 °C
(denaturation), and 1 min at 60 °C (annealing plus ex-
tension). Gene expression was normalized using the
geometrical mean of three appropriate internal control
genes: GAPDH and RPS9 for all tissues, along with ACTB
for adipose and UXT for liver and PMNL [25, 27, 30].
Genes were considered not expressed when the standard
curve had slope -3.50 > y > -3.00 and Ct > 30. At least for
the Ct threshold, the criterion is consistent with our estab-
lished protocols aimed in part at reducing the unreliability
of data that often occurs at >30 Ct [25, 27, 28, 30]. In that
context, it is important to highlight that in recent studies
dealing with the study of FFAR the mean Ct for quantifi-
cation of GPR40 (which was undetectable using our
thresholds) ranged from 31.4 for adipose and liver [31] to
35.7 for adipose [32]. Although it could be possible that
the size of the amplicon for the GPR40 primer [29]
was too long and led to poor amplification efficiency,
Yonezawa et al. [29] verified the identity of bovine
GPR40 by sequencing (as did we; see Additional Table S2)
and used it successfully with bovine mammary tissue. Un-
fortunately, there was no information on amplicon size for
the GPR40 primer used in the work of Friedrichs et al.
[31, 32]. The qPCR performance is reported for adipose,
liver, and PMNL in Additional file 1: Table S3.
Statistical analysis
Prior to analysis, expression data were log2 normalized.
All data sets (i.e.: blood parameters, energy balance, and
qPCR) were then subject to ANOVA using repeated
measures ANOVA with PROC MIXED in SAS (v 9.2; SAS
Institute Inc., Cary, NC). The statistical model for adipose
included time (-10, +7, +20 d), BCS (HI, LO), and their
interaction as fixed effects. Energy balance was analyzed
pre- and postpartum. The model for liver and PMNL gene
expression, and blood parameters, included time (-10, +7,
+30 d), methionine supplementation (MET, CON), and
their interaction as fixed effects. The random effect was
cow, nested within treatment. The Kenward-Roger state-
ment was used for computing the denominator degrees of
freedom, with sp(pow) as the covariance structure. Energy
balance used Compound Symmetry as the covariance
structure postpartum. Previous 305 d lactation and parity
were used as covariates for blood analysis, and parity was
used as a covariate for energy balance. When not signifi-
cant, covariates were removed from the model. Data were
considered significant at P ≤ 0.05 using the PDIFF state-
ment in SAS. Expression data in Tables 3 and 5 are re-
ported as the log2 back-transformed least squares means.
Results
Body condition score experiment
Energy balance
Although there was no difference in energy balance by
BCS prepartum (P = 0.86) (Table 2), cows in the HI BCS
group were in more NEB (P = 0.03) during the postpar-
tum period.
Adipose
GPR40 was not expressed in adipose tissue. GPR84 ex-
pression was significantly lower (P < 0.05) prepartum
than postpartum (Table 3). There was also an interaction
effect (P = 0.03) of BCS × time, such that expression was
higher in LO than in HI cows at +7 d. There was also a
significant time effect (P < 0.01) on expression of GPR120,
where expression was highest prepartum, and decreased
at both of the postcalving time points. Expression of both
GPR120 and GPR109A tended (P = 0.08 and 0.06) to be
greater in LO than in HI. There was also a tendency
(P = 0.08) due to the time effect on GPR109A, mainly
for the difference between +7 and +20 d.
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Rumen-protected methionine experiment
Inflammation and oxidative stress biomarkers
Overall, cows in MET had lower (P < 0.05) concentrations
of IL-1β and ROM but had greater (P < 0.05) concentra-
tion of MPO (Table 4).
Liver
Neither GPR40 nor GPR120 were expressed in liver
(Table 5). For GPR84 and GPR109A, there were no sig-
nificant differences (P > 0.15) or tendencies for effects of
MET, time, or the interaction.
PMNL
GPR120 was not expressed in PMNL (Table 5). Among
the other three genes, there were significant differences
(P < 0.05) between MET and CON for GPR40 and GPR84,
such that GPR40 was lower in MET, and GPR84 was
higher in MET. GPR40 expression also differed across
time (P = 0.04), such that cows had significantly greater
expression at -10 d than at +30 d, decreasing (albeit not
significantly) in between. GPR109A tended (P = 0.09) to be




Postpartum, transition cows can experience stress-in-
duced, pathogen-independent inflammation, as marked by
pro-inflammatory cytokines and acute-phase proteins
(APP) in the blood [33]. Furthermore, expression of che-
moattractants and cytokines within adipose tissue indi-
cates some degree of local inflammation, which has been
postulated as a homeorhetic mechanism to aid lactation
[34, 35]. This theory is supported by the knowledge that
cytokines present during inflammation encourage lipolysis
[34], the “metabolic hallmark” of transition [36]. Here,
both the function and the temporal expression of GPR84
match physiologic adaptations in the cow, indicating that
effects of inflammation in adipose are partly mediated
through this receptor.
An interaction of BCS × time at +7 d, where LO cows
had much greater expression of GPR84 than HI cows
also provides evidence of the pro-inflammatory role for
GPR84 in cattle. Biomarkers like haptoglobin, bilirubin,
and paraoxonase have been used to indicate peripartal
inflammation through the first 2-3 wk of lactation [37].
Here, although blood biomarker data were unavailable,
the surge in GPR84 expression may also indicate greater
inflammation in LO cows, at least within the adipose tis-
sue depot [38]. This may not necessarily be mirrored at
a systemic level since cows with higher BCS are nor-
mally associated with greater overall inflammation and
lower health status [13]. Despite this, thin cows can still
be health-compromised during the transition period
[13, 39]. Barring clinical or subclinical disease, inflamma-
tory signals resolve toward the end of the transition period
[37], which parallels the return of GPR84 expression to
prepartum levels.
If the above holds true, GPR84-mediated inflammation
could also help explain production in these cows. In-
flammation in early lactation has been connected with
poorer performance (i.e. milk yield; [33]), and in fact,
Table 3 Log2-backtransformed least squares means of adipose gene expression data in transition cows with high (HI; BCS≥ 3.75) or
low (LO; BCS ≤ 3.25) body condition score at -10, +7, and +20 d from calving
BCS × Time
Gene BCS1 Time HI LO SEM2 P-value
HI LO −10 +7 +20 −10 +7 +20 −10 +7 +20 BCS Time BCS × Time
GPR40 Not expressed
GPR84 0.37 0.41 0.19a 0.69b 0.46b 0.21a 0.39a,b* 0.61b 0.17a 1.21b* 0.34a 0.40 0.62 <0.01 0.03
GPR120 0.46 0.72 1.69a 0.49b 0.22c 1.36 0.37 0.19 2.09 0.67 0.26 0.64 0.08 <0.01 0.89
GPR109A 1.05 1.30 1.12 1.40 1.02 1.13 1.16 0.89 1.10 1.68 1.17 0.22 0.06 0.08 0.33
a,b,cStatistical difference (P < 0.05) among time points within the same group
*Statistical difference (P < 0.05) between groups within time points
1Body condition score
2Largest standard error of the mean
Table 4 Least squares means of immune biomarker concentrations
in blood in transition cows supplemented with rumen-protected
methionine (MET) or unsupplemented (CON) at -10, +7, and +30
d. This data only represents the subset of cows used for
polymorphonuclear leukocyte (PMNL) gene expression
Parameter Diet SEM1 P-value
MET CON Diet Time Diet × Time
IL-1β2 3.63a 5.74b 0.69 0.05 0.17 0.70
ROM 12.29a 14.20b 0.23 <0.01 <0.01 0.05
MPO 466.87a 405.18b 15.89 0.02 0.14 0.44
a,bStatistical difference (P ≤ 0.05) among time points within the same group
1Largest standard error of the mean
2Significance (P < 0.05) for parity in the model
Agrawal et al. Journal of Animal Science and Biotechnology  (2017) 8:20 Page 5 of 10
through the first month, milk yield from LO cows was
numerically, albeit not statistically, lower than HI cows
(39 kg/d vs. 42 kg/d; data not shown). In a recent study
[17], Pires et al. obtained similar results: numerically,
low BCS cows had lower production than medium or
high BCS cows. Further work including more cows, as
well as immune biomarkers concurrent with gene ex-
pression, will be necessary to elucidate the potential in-
volvement of GPR84 and validity of such relationships.
Contrary to GPR84, GPR120 is primarily an anti-
inflammatory receptor [8]. Thus, lower expression over
time potentially reinforces evidence of postpartal inflam-
mation, although without a lessening effect by 3 week
postpartum. Its metabolic role may explain this pattern:
GPR120 stimulates adipogenesis and differentiation, ra-
ther than lipolysis [40]. As necessity for lipolysis increases
through early lactation NEB [14], expression of GPR120
should decrease, as observed here. Receptor activation in
adipose also improves insulin sensitivity [41]. Because in-
sulin resistance in peripheral tissues is important for push-
ing available glucose to the mammary gland post-calving
[42], lower expression of GPR120 in adipose should be ex-
pected, and may be a necessary part of the transcriptome
adaptation to milk synthesis.
To a lesser extent, limited expression could also be a
regulatory mechanism. As lipolysis occurs, releasing pri-
marily long-chain FA (LCFA) (i.e. GPR120 ligands) to
the blood [43], signaling may provide negative feedback
to prevent hyperactivation. In some cases, GPR120 can
activate β-arrestin2, which promotes receptor internal-
ization and prevents continuous ligand-sensing [44];
perhaps gene expression is used as an additional level of
control, or acts as a primary regulatory mechanism
when alternate pathways are activated.
Both of the above ideas may explain why HI cows
tended to have lower overall GPR120 expression. As pre-
viously mentioned, milk yield of HI cows was ~3 kg/d
greater, numerically. Greater milk production translates
to greater glucose requirements [36], and gene expres-
sion should reflect a heightened need for peripheral in-
sulin resistance. To produce milk during NEB, HI cows
may also mobilize more of their body fat reserves which
we also detected in this study, leading to higher FA
mobilization and circulating FA [16, 39]. The marked
NEB postpartum in HI cows supports this idea. As
GPR120 interacts with free LCFA, a negative response on
gene expression may prevent further signaling at a time
when that could be counterproductive. Certainly, going
forward, this receptor could be an interesting metabolic
target in the transition period.
The finding that GPR109A tends to have greater ex-
pression in LO than in HI cows is not surprising. Studies
of GPR109A indicated that it is a primary anti-lipolytic
receptor in adipose tissue [45]. The lower BCS in LO
cows was indicative of potentially lower amount of stored
fat, and greater expression of this receptor could be a
mechanism to maintain as much of their already-reduced
body condition as possible. Smaller BCS losses between
the beginning of the close-up period (-21 d) and both
postpartum time points (+21 d) in LO cows compared
with HI cows may provide evidence in support of this hy-
pothesis (BCS loss of 0.80 versus 0.40). To address the
species-specific effects of GPR109A on lipolysis, that is,
whether in ruminants it has temporary and/or rebound ef-
fects as in humans, or longer-term FA-lowering effects as
in rodents [46], plasma FA from multiple time points
should be considered. Although no blood data were avail-
able for the subset of cows with adipose biopsies, amount
Table 5 Log2-backtransformed least squares means of liver and polymorphonuclear leukocyte (PMNL) gene expression data in
transition cows supplemented with rumen-protected methionine (MET) or unsupplemented (CON) at -10, +7, and +30 d from calving
Diet × Time
Gene Diet Time MET CON SEM1 P-value
MET CON −10 +7 +30 −10 +7 +30 −10 +7 +30 Diet Time Diet × Time
Liver
GPR40 Not expressed
GPR84 0.77 0.84 0.88 0.74 0.80 0.85 0.73 0.75 0.91 0.75 0.86 0.14 0.64 0.25 0.89
GPR120 Not expressed
GPR109A 0.51 0.53 0.64 0.48 0.46 0.57 0.52 0.44 0.72 0.44 0.47 0.15 0.77 0.22 0.61
PMNL
GPR40 0.85* 1.13* 1.15a 0.95a,b 0.85b 1.00 0.80 0.77 1.33 1.14 0.94 0.17 0.04 0.04 0.78
GPR84 1.49* 0.65* 0.96 1.05 0.96 1.22 1.82 1.49 0.75 0.60 0.61 0.64 0.04 0.93 0.51
GPR120 Not expressed
GPR109A 1.34 0.87 1.26 0.91 1.10 1.42 1.31 1.28 1.11 0.63 0.94 0.44 0.09 0.60 0.71
a,bStatistical difference (P < 0.05) among time points within the same group
*Statistical difference (P < 0.05) between groups within time points
1Largest standard error of the mean
Agrawal et al. Journal of Animal Science and Biotechnology  (2017) 8:20 Page 6 of 10
of circulating FA can be correlated with energy balance
(EB) [36]. Thus, with better EB (i.e.: more shallow NEB)
than HI cows at both time points postpartum, it can be as-
sumed that LO cows had lower circulating FA, meaning
that GPR109A may be effective over some period of time
in cattle. Blood analyses will be useful to confirm this idea.
For this reason, a tendency for greater GPR109A ex-
pression +7 d after calving, regardless of BCS, was unex-
pected. The nadir in energy balance, when low DMI
coincides with high lactation requirements, typically oc-
curs within three weeks following calving. As previously
mentioned, this tends to correspond with lipomobiliza-
tion; in fact, peak levels of basal and norepinephrine-
stimulated lipolysis occur around +10 d [14]. Thus, it
appears that high rates of lipolysis can occur in spite of
the anti-lipolytic influence of GPR109A.
This could be due to a greater net signal for fat
mobilization over storage brought on by calving and initi-
ation of lactation. Because GPR109A signaling involves a
decrease in cAMP levels that inhibits hormone-sensitive
lipase and prevents release of FA [45], it is possible that
parturition- and lactation-induced flux in hormone levels
themselves (e.g., increased catecholamines and decreased
insulin) are more influential on hormone-sensitive lipase
than GPCR signaling [47]. More information could be-




It is not altogether surprising that the genes of interest
were not expressed, or were expressed at low levels in
the liver. Although these GCPR can be widely expressed
throughout the body [8], few studies identified the liver
as a major site of expression for these particular genes.
In fact, GPR40 [46, 47] and GPR109A [43, 48] have been
reported as not detected in liver, and GPR120 has been re-
ported as not detected, except in Kupffer cells (i.e.: macro-
phages), in the liver [49, 50]. In the present study, the fact
that GPR40 and GPR120 were not detected agrees with
the literature.
The barely detectable expression of GPR109A and GPR84,
and the lack of differences between groups or across time,
indicates that these genes may typically be expressed at very
low levels, if at all, in bovine liver. Greater numbers of cows,
and/or protein detection methods, should be used in future
studies to confirm the presence or absence of these recep-
tors within the liver.
Nonetheless, the genes of interest do play an important
role in function and diseases in the liver. It is therefore
plausible that effects of these GPCR on the liver are
mostly indirect, as a result of signaling that originates
in other peripheral tissues or immune cells. Notably, the
acute, insulin-promoting effects of GPR120 [41], and
GPR109A signaling to reduce hormone-sensitive lipase
[45] in adipose tissue, could protect against excess lipid
mobilization preceding fatty liver. Conversely, activation
of GPR40 in pancreatic β-cells could signal hyperinsuline-
mia and increased risk of lipid accumulation in the liver
[51]. Therefore, for the present genes of interest, systemic
metabolic networks – rather than localized pathways –
may provide better insight as to hepatic responses in
bovines. Alternatively, other families of receptors, e.g.,
peroxisome proliferator-activated receptor (PPAR), could
contribute more to direct outcomes of relevant ligands
(i.e.: LCFA) in the liver [52].
PMNL
Neutrophils are the only tissue in which GPR40 was
detected. Since GPR40 has already been implicated in
calcium-dependent degranulation and superoxide pro-
duction in bovine neutrophils [53], its presence was
certainly expected. Its downregulation over time suggests
lower PMNL activity postpartum. Indeed, it is well-known
that hormones and NEB contribute to immunosuppres-
sion post-calving [54–56]. However, it is curious that
MET cows had lower expression than CON despite having
greater phagocytosis and oxidative burst capacity when
challenged in vitro with a bacterial pathogen [20] and
higher plasma levels of myeloperoxidase (Table 4) [20].
Instead, it seems that MET could indirectly affect GPR40
expression through substrate (i.e. fatty acid) availability, be-
cause inflammation can promote lipolysis [57], but MET
supplementation appears to benefit the inflammatory
status (i.e. lower IL-1 β and ROM) [34]. However, MET
supplementation did not affect circulating FA levels
[21]. Thus, the role of MET supplementation in regulat-
ing GPR40 expression needs further investigation.
In contrast, GPR84 upregulation in MET agrees with
previous data describing enhanced immune response (i.e.:
phagocytosis and respiratory burst) in these cows [20].
GPR84 expression can be stimulated by lipopolysaccharide
(LPS), and subsequent signaling produces pro-inflammatory
signals, demonstrating that receptor function is tied to im-
mune responses [10]. In agreement, in vivo data revealed
that supplementation with MCFA (i.e.: GPR84 ligands) in
the transition period lessened neutrophil apoptosis [58],
thereby improving antimicrobial capacity of the cells [59]. S
Piepers and S De Vliegher [58] hypothesized that GPCR
signaling could be at least partly responsible for the im-
provement in cell viability, and the present study provides
evidence that GPR84 could specifically play a role.
Interestingly, GPR109A also tended to be upregulated in
MET PMNL vs. CON. Like GPR84, GPR109A expression
can be induced by LPS [12], yet with opposite outcome:
GPR109A activates apoptosis in neutrophils [60]. As noted
above, apoptosis should correspond with lower PMNL
function, but this did not occur. On the other hand,
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because apoptosis promotes resolution of inflammation
[61], GPR109A expression concurs with the largely anti-
inflammatory environmental conditions. Possibly, with the
influence of MET to lower inflammation (as demonstrated
by Zhou et al. [21]), neutrophils maintain their function
over a short lifespan [62]. To aid in rapid clearance of
aged neutrophils and maintenance of a stable environ-
ment, MET cells would induce apoptosis versus necrosis
[61]. In this way, GPR109A may help protect transition
cows from chronic inflammation. More in-depth studies
would be needed, but if true, this could provide a new
context in which to study niacin as a transition feed sup-
plement [63–65].
Conclusions
Conditions which are present in ruminants and cause
metabolic disorders and clinical disease near calving: nega-
tive energy balance, lipid mobilization, insulin resistance,
and immunosuppression, closely resemble dysregulated
metabolic systems in human diseases. Thus, molecular tar-
gets in human medicine may translate as targets for the
transition cow. The present GPCR show promise for such
work. Although none were expressed well in the liver, their
contributions to inflammation, insulin resistance, and lip-
olysis in adipose indicate that they may indirectly affect
liver accumulation of fat. The GPCR-modulated environ-
ment may also contribute to level of milk production and
severity of systemic inflammation in early lactation. Add-
itionally, the differences between BCS groups highlight the
role of the transcriptome in coordinating lipid metabolism
and energy status, and differences between MET and CON
reinforce previous findings and demonstrate potential
networks for immune-enhancing action of supplemental
methionine. Thus, the present GPCR and related recep-
tors (e.g., FFAR2 and FFAR3) are suggested as continued
areas of research in bovine to improve transition health.
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